Company Filing History:
Years Active: 1997-1998
Title: Kouhei Yazawa: Innovator in Platelet Aggregation Inhibitors
Introduction
Kouhei Yazawa is a notable inventor based in Chiba-ken, Japan. He has made significant contributions to the field of medicine, particularly in the development of platelet aggregation inhibitors. With a total of 2 patents to his name, Yazawa's work is focused on innovative compounds that have the potential to improve patient outcomes in cardiovascular treatments.
Latest Patents
Yazawa's latest patents include two groundbreaking inventions. The first patent pertains to amidine derivatives and a platelet aggregation inhibitor containing these derivatives. This invention relates to a substituted amidine derivative that exhibits excellent platelet aggregation inhibiting action based on fibrinogen antagonism. It is particularly effective when administered orally, making it a promising candidate for the prevention and treatment of thrombosis, as well as restenosis or reocclusion following procedures like percutaneous transluminal coronary angioplasty or recanalization.
The second patent involves a bicyclic compound and a platelet aggregation inhibitor that incorporates this compound. This novel compound, represented by a specific formula, also demonstrates excellent platelet aggregation inhibiting action based on fibrinogen antagonism. The platelet aggregation inhibitor containing this compound is effective for the prevention and treatment of thrombosis and restenosis or reocclusion after similar medical procedures.
Career Highlights
Kouhei Yazawa is currently employed at Mitsui Toatsu Chemicals, Incorporated, where he continues to innovate in the field of pharmaceutical chemistry. His work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Yazawa collaborates with esteemed colleagues, including Kunio Okumura and Toshiyuki Shimazaki. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Kouhei Yazawa's contributions to the development of platelet aggregation inhibitors highlight his role as a significant innovator in the medical field. His patents reflect a dedication to improving therapeutic options for patients at risk of cardiovascular complications.